Quick Takeaways
- Bradley L. Radoff filed SCHEDULE 13D for Atea Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AVIR).
- Disclosed ownership: 3.3%.
- Date of event: 27 Feb 2025.
Quoteable Key Fact
"Bradley L. Radoff disclosed 3.3% ownership in Atea Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AVIR) on 27 Feb 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Radoff Family Foundation | 0.2% | 165,000 | 0 | 165,000 | /s/ Bradley L. Radoff | Bradley L. Radoff, Director | 0001496916 |
| Radoff Bradley Louis | 3.3% | 2,820,000 | 2,655,000 | 165,000 | /s/ Bradley L. Radoff | Bradley L. Radoff | 0001380585 |
| JEC II Associates, LLC | 1.5% | 1,300,000 | 0 | 1,300,000 | /s/ Michael Torok | Michael Torok, Manager | 0001477326 |
| The MOS Trust | 0.1% | 100,000 | 0 | 100,000 | /s/ Michael Torok | Michael Torok, Manager of MOS PTC, LLC, its Trustee | |
| MOS PTC, LLC | 0.1% | 100,000 | 0 | 100,000 | /s/ Michael Torok | Michael Torok, Manager | |
| Torok Michael | 1.8% | 1,500,000 | 100,000 | 1,400,000 | /s/ Michael Torok | Michael Torok | 0001967237 |